ONCOCROSS

  • Company

    • Mission

    • About Us

    • History

    • Leadership

    • Scientific Advisory Board

  • Business Areas

    • Neo Omics

    • DBB

    • Early Cancer Detection & Monitoring

    • Collaboration

  • Technology Platform

    • RAPTOR AI® VERSION 2.0

    • ONCOfind AI ®

  • Pipeline

  • News/IR

    • Notice

    • Press Releases

    • IR Materials

    • Knowledge Hub

    • Latest Cancer Information

    • Disclosure Information

    • Stock Information

  • OncoMaster

CONTACT US
  • KR
  • EN
  • Company

    • Mission

    • About Us

    • History

    • Leadership

    • Scientific Advisory Board

  • Business Areas

    • Neo Omics

    • DBB

    • Early Cancer Detection & Monitoring

    • Collaboration

  • Technology Platform

    • RAPTOR AI® VERSION 2.0

    • ONCOfind AI ®

  • Pipeline

  • News/IR

    • Notice

    • Press Releases

    • IR Materials

    • Knowledge Hub

    • Latest Cancer Information

    • Disclosure Information

    • Stock Information

  • OncoMaster

  • KR
  • EN
CONTACT US
  • Main
  • News/IR
  • Press Releases

Press Releases

181 Posts
  • 메트로미디어

    'Good AI 어워드' 개최...LG AI 연구원이 영예의 대상 수상

    12-20-2022
  • 디지틀조선일보

    “AI 기술·윤리 모두 잘한 기업은?”…‘Good AI 어워드’ 개최

    12-14-2022
  • Weixin

    阿尔法分子与OncoCoss签署GPCR共同新药研发合作协议

    11-01-2022
  • 바이오타임즈

    온코크로스, 스위스 알파몰과 간경화 치료제 공동연구 개발 계약

    11-01-2022
  • 청년의사

    가천대길병원-온코크로스, AI 의료기술·기기 연구 협력키로

    09-29-2022
  • BioTimes

    온코크로스, 가천대 길병원 가천의생명융합연구원과 공동 연구 협력

    09-29-2022
  • Marktechpost

    Top Innovative Artificial Intelligence (AI) Powered Startups Based in South Korea

    09-21-2022
  • 헬스코리아뉴스

    인공지능 기반 신약개발 열기 뜨겁다

    09-16-2022
  • 히트뉴스

    AI신약개발협의회 발족, '협업 생태계' 조성

    07-14-2022
  • 식약신문

    AI신약개발협의회 발족 ‘협업 생태계’ 조성

    07-14-2022
  • Cyclica

    Cyclica and Oncocross announce partnership to develop therapeutics in oncology

    06-08-2022
  • 바이오타임즈

    온코크로스, 캐나다 씨클리카와 골수섬유증 치료제 공동 연구개발 협력

    06-07-2022
  • «
  • ‹
  • 6
  • 7
  • 8
  • 9
  • 10
  • ›
  • »

Please enter a prompt

ONCOCROSS
CEO
Yi Rang KIM / Jihoon KANG
Address
Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)
Tel
02-717-9967
Fax
02-867-9968
Email
oncocross@oncocross.com
Terms & Conditions Privacy Policy Cookie Policy
ⓒ ONCOCROSS CO., LTD. All Rights Reserved.